Progestin

Levonorgestrel

Approved 30 Sept 2025OralTablet

The FDA lists this product in 19 strengths and forms.

Indications

Use for women to reduce chance of pregnancy after unprotected sex (if a contraceptive failed or if you did not use birth control)

Warnings and precautions

Warnings Allergy alert: Do not use if you have ever had an allergic reaction to levonorgestrel Sexually transmitted diseases (STDs) alert: This product does not protect against HIV/AIDS or other STDs

Composition

Active ingredients: LEVONORGESTREL 1.5MG

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

LEVONORGESTREL 0.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletANDA078665-001 · Discontinued

LEVONORGESTREL 0.75MG · TabletANDA091328-002 · Over the counter

LEVONORGESTREL 0.75MG · TabletANDA091328-001 · Discontinued

LEVONORGESTREL 1.5MG · TabletANDA202334-001 · Over the counter

LEVONORGESTREL 1.5MG · TabletANDA202380-001 · Over the counter

LEVONORGESTREL 0.75MG · TabletANDA202684-001 · Discontinued

LEVONORGESTREL 1.5MG · TabletANDA205329-001 · Over the counter

LEVONORGESTREL 1.5MG · TabletANDA204044-001 · Over the counter

LEVONORGESTREL 1.5MG · TabletANDA207660-001 · Over the counter

LEVONORGESTREL 0.75MG · TabletANDA202740-001 · Discontinued

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA219102.

Open Drugs@FDA

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.